HDL, its enzymes and its potential to influence lipid peroxidation

Gordon, 1992, 17

Durrington, 1989

Steinberg, 1989, Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity, New Engl J Med, 320, 915, 10.1056/NEJM198904063201407

Witztum, 1991, Role of oxidized low density lipoprotein in atherogenesis, J Clin Invest, 88, 1785, 10.1172/JCI115499

Steinbrecher, 1989, Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products fatty acid peroxidation, J Biol Chem, 264, 15 216, 10.1016/S0021-9258(19)84812-3

Kodama, 1990, Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils, Nature, 343, 531, 10.1038/343531a0

Rohrer, 1990, Coiled coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II, Nature, 343, 570, 10.1038/343570a0

Endemann, 1993, CD36 is a receptor for oxidised low density lipoprotein, J Biol Chem, 268, 11 811, 10.1016/S0021-9258(19)50272-1

Stanton, 1992, The macrophage Fc receptor for IgG is also a receptor for oxidised low desnsity lipoprotein, J Biol Chem, 267, 22 446, 10.1016/S0021-9258(18)41692-4

Rosenfeld, 1992, Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans, Am J Pathol, 140, 291

Rice-Evans, 1992, Free radicals, lipoproteins and cardiovascular dysfunction, Mol Aspects Med, 13, 1, 10.1016/0098-2997(92)90002-H

Liu, 1992, Oxidative status of lipoproteins in coronary disease patients, Am Heart J, 123, 285, 10.1016/0002-8703(92)90636-A

Nishigaki, 1991, Lipid peroxide levels of serum lipoprotein fractions of diabetic patients, Biochem Med, 25, 378

Stampfer, 1993, Vitamin E consumption and the risk of coronary disease in women, New Engl J Med, 328, 1444, 10.1056/NEJM199305203282003

Regnstrom, 1992, Susceptibility to low density lipoprotein oxidation and coronary atherosclerosis in man, Lancet, 339, 1183, 10.1016/0140-6736(92)91129-V

Babiy, 1992, Increased oxidizability of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due to glycation, Biochem Pharmacol, 43, 995, 10.1016/0006-2952(92)90604-H

Salonen, 1992, Autoantibody against oxidised LDL and progression of carotid atherosclerosis, Lancet, 339, 883, 10.1016/0140-6736(92)90926-T

Ylä-Herttuala, 1990, Colocalisation of 15-lipoxygenase mRNA and protein with epitopes of low density lipoprotein in macrophage-rich areas of atherosclerotic lesion, 87, 6959

Esterbauer, 1992, The role of lipid peroxidation and antioxidants in oxidative modification of LDL, Free Rad Biol Med, 13, 341, 10.1016/0891-5849(92)90181-F

Meister, 1992, On the antioxidant effects of ascorbic acid and glutathione, Biochem Pharmacol, 44, 1905, 10.1016/0006-2952(92)90091-V

Ingold, 1993, Autoxidation of lipids and antioxidation by alpha-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids: unrecognised consequences of lipid particle size as exemplified by oxidation of human low density lipoprotein, 90, 45

Smith, 1990, Factors influencing the accumulation in fibrous plaques of lipid derived from low density lipoprotein. II: preferential immobilization of lipoprotein (a), Atherosclerosis, 84, 173, 10.1016/0021-9150(90)90088-Z

Kreuzer, 1994, Lipoprotein (a) displays increased accumulation compared with low density lipoprotein in murine arterial wall, Chem Phys Lipids, 67/68, 175, 10.1016/0009-3084(94)90137-6

Klimov, 1987, Antioxidative effect of high density lipoproteins in the oxidation of low density lipoproteins, Bull Exp Biol Med (Russ), 103, 550

Ohta, 1989, Protective effect of lipoproteins containing apolipoprotein A-I on Cu2+-catalyzed oxidation of human low density lipoprotein, FEBS Lett, 257, 435, 10.1016/0014-5793(89)81590-X

Mackness, 1991, Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein, FEBS Lett, 286, 151, 10.1016/0014-5793(91)80962-3

Mackness, 1993, The role of high density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low density lipoprotein oxidation, Biochem J, 294, 829, 10.1042/bj2940829

Parthasarathy, 1990, High density lipoprotein inhibits the oxidative modification of low density lipoprotein, Biochim Biophys Acta, 1044, 275, 10.1016/0005-2760(90)90314-N

Miyazaki, 1994, Acetylated low density lipoprotein reduces its ligand activity for the scavenger receptor after interaction with reconstituted high density lipoprotein, J Biol Chem, 269, 5264, 10.1016/S0021-9258(17)37683-4

Klimov, 1993, Antioxidative activity of high density lipoproteins in vivo, Atherosclerosis, 100, 13, 10.1016/0021-9150(93)90063-Z

Eisenberg, 1984, High density lipoprotein metabolism, J Lipid Res, 25, 1017, 10.1016/S0022-2275(20)37713-0

Chander, 1990, High density lipoprotein is a scavenger of superoxide anions, Biochem Pharmacol, 40, 1663, 10.1016/0006-2952(90)90469-2

Kunitake, 1992, Binding of transition metals by apolipoprotein A-I containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins, 89, 6993

Sattler, 1993, Greater selective uptake by Hep G2 cells of high density lipoprotein cholesterylester hydroperoxides than of unoxidised cholesteryl esters, Biochem J, 294, 771, 10.1042/bj2940771

Hessler, 1979, LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cell in culture, Atherosclerosis, 32, 213, 10.1016/0021-9150(79)90166-7

Morel, 1983, Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid, J Lipid Res, 24, 1070, 10.1016/S0022-2275(20)37921-9

Hessler, 1983, Lipoprotein oxidation and lipoprotein induced cytotoxicity, Arteriosclerosis, 4, 357

Chung, 1989, Lipolytic surface remnants of triglyceride-rich lipoproteins are cytotoxic to macrophages but not in the presence of high density lipoprotein, J Clin Invest, 83, 1363, 10.1172/JCI114024

Speidel, 1990, Lipolyzed hypertriglyceridemic serum and triglyceride-rich lipoprotein cause lipid accumulation in and are cytotoxic to cultured human endothelial cells. High density lipoproteins inhibit this cytotoxicity, Thromb Res, 58, 251, 10.1016/0049-3848(90)90095-T

Zwijsen, 1991, Modulation of low-density lipoprotein induced inhibition of intracellular communications by antioxidants and high density lipoproteins, Fd Chem Toxic, 29, 615, 10.1016/0278-6915(91)90143-U

Schmidt, 1992, High density lipoprotein antagonizes the inhibitory effects of oxidised low density lipoprotein and lysolecithin on soluble gyanyl cyclase, Biochem Biophys Res Commun, 182, 302, 10.1016/S0006-291X(05)80145-7

Navab, 1991, Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein, J Clin Invest, 88, 2039, 10.1172/JCI115532

Blatter, 1993, Identification of a distinct human high density lipoprotein sub-species defined by a lipoprotein-associated protein, K-45, Eur J Biochem, 211, 871, 10.1111/j.1432-1033.1993.tb17620.x

Mackness, 1989, ‘A’-esterases — enzymes looking for a role?, Biochem Pharmacol, 38, 385, 10.1016/0006-2952(89)90376-6

Adkins, 1993, Molecular basis for the polymorphic forms of serum paraoxonase/arylesterase, Am J Hum Genet, 52, 598

Humbert, 1993, The molecular basis of the human serum paraoxonase activity polymorphism, Nat Genet, 3, 73, 10.1038/ng0193-73

McElveen, 1986, Distribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction, Clin Chem, 32, 671, 10.1093/clinchem/32.4.671

Mackness, 1991, Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus, Atherosclerosis, 86, 193, 10.1016/0021-9150(91)90215-O

Mackness, 1993, Protection of low density lipoprotein against oxidative modification by high density lipoprotein associated paraoxoase, Atherosclerosis, 104, 129, 10.1016/0021-9150(93)90183-U

Wilkins, 1994, Prevention of macrophage oxidation of low density lipoprotein by paraoxonase

Klimov, 1989, The protective action of high density lipoproteins, their subfractions, and lecithin-cholesterol acyltransferase in the peroxide modification of low density lipoproteins, Biokhimiya, 54, 118

Subbaiah, 1980, Low density lipoprotein-activated lysolecithin acylation by human plasma lecithin-cholesterol acyltransferase, J Biol Chem, 255, 9275, 10.1016/S0021-9258(19)70558-4

Stremler, 1991, Human plasma platelet-activating factor acytylhydrolase: oxidatively fragmented phospholipids as substrates, J Biol Chem, 266, 11 095, 10.1016/S0021-9258(18)99132-5

Stafforini, 1987, Human plasma platelet-activating factor acetylhydrolase: association with lipoprotein particles and role in the degradation of platelet-activating factor, J Biol Chem, 262, 4215, 10.1016/S0021-9258(18)61335-3

Hoener, 1992, Phosphatidylinositol-glycan-specific phospholipase D is an amphiphilic glycoprotein that in serum is associated with high density lipoproteins, Eur J Biochem, 206, 747, 10.1111/j.1432-1033.1992.tb16981.x

Hoener, 1993, Glycosyl phosphatidylinositol-specific phospholipase D: interaction with and stimulation by apolipoprotein A-1, FEBS Lett, 327, 203, 10.1016/0014-5793(93)80170-Y

Bellon, 1981, Elastase-type activity associated with high density lipoproteins in human serum, Biochem Biophys Res Commun, 1103, 331

Vainio, 1980, Esterase type of activity possessed by human plasma apolipoprotein C-III and its synthetic fragments, Chem Phys Lipids, 33, 21, 10.1016/0009-3084(83)90004-X

Durrington, 1994